# LIANY (LianBio) - SEC EDGAR Financial Statements

> LianBio reported $262.9M in total assets and a net loss of $87.98M through December 31, 2022 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/LIANY
- Markdown: https://convexityos.com/fundamentals/LIANY.md
- SEC CIK: 0001831283
- Reporting currency: USD
- Latest filing period: September 30, 2023
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001831283&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2022 | -- | Dec 31, 2022 |
| Operating Income | FY 2022 | -$106.6M | Operating profit |
| Net Income | FY 2022 | -$87.98M | GAAP bottom line |
| Diluted EPS | FY 2022 | -$0.82 | Split-adjusted |
| Free Cash Flow | FY 2022 | -$83.99M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2023 | $252.2M | Total debt: $2.84M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- |
| Research & Development | $59.76M | $158.7M | $120.9M |
| Total Operating Expenses | $125.4M | $195.6M | $134.9M |
| **Operating Income** | -$125.4M | -$195.6M | -$134.9M |
| **EBITDA** | -$124.3M | -$195.0M | -$134.8M |
| Income Before Tax | -$110.6M | -$195.8M | -$139.6M |
| Income Tax Expense | -$333K | $518K | $4.0K |
| **Net Income** | -$110.3M | -$196.3M | -$139.6M |
| Basic EPS | -$1.02 | -$5.71 | -$11.58 |
| **Diluted EPS** | -$1.02 | -$5.71 | -$11.58 |
| Basic Shares Outstanding | 107.9M | 34.4M | 12.1M |
| Diluted Shares Outstanding | 107.9M | 34.4M | 12.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $9.02M | $9.45M | $10.83M | $10.58M | $8.26M | $28.59M | $12.33M | $7.65M |
| Total Operating Expenses | $26.30M | $25.04M | $25.97M | $29.25M | $24.55M | $43.14M | $28.42M | $22.04M |
| **Operating Income** | -$26.30M | -$25.04M | -$25.97M | -$29.25M | -$24.55M | -$43.14M | -$28.42M | -$22.04M |
| **EBITDA** | -$26.00M | -$24.74M | -$25.64M | -$28.93M | -$24.35M | -$42.94M | -$28.15M | -$21.79M |
| Income Tax Expense | $586K | $200K | $438K | -$350K | $6.0K | $5.0K | $6.0K | -$1.03M |
| **Net Income** | -$24.04M | -$21.62M | -$24.05M | -$18.28M | -$21.90M | -$42.39M | -$27.73M | -$21.20M |
| Basic EPS | -$0.22 | -$0.20 | -$0.22 | -- | -$0.20 | -$0.39 | -$0.26 | -- |
| **Diluted EPS** | -$0.22 | -$0.20 | -$0.22 | -- | -$0.20 | -$0.39 | -$0.26 | -- |
| Basic Shares Outstanding | 107.2M | 107.2M | 107.2M | -- | 108.4M | 107.9M | 107.3M | -- |
| Diluted Shares Outstanding | 107.2M | 107.2M | 107.2M | -- | 108.4M | 107.9M | 107.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $79.22M | $228.2M | $254.3M |
| Short-Term Investments | $223.1M | $155.1M | $0 |
| **Cash & Short-Term Investments** | $302.4M | $383.2M | $254.4M |
| **Total Current Assets** | $312.8M | $399.6M | $276.7M |
| Property, Plant & Equipment, Net | $3.12M | $1.88M | $822K |
| Other Non-Current Assets | $20K | $51K | $12K |
| **Total Non-Current Assets** | $7.19M | $26.70M | $2.54M |
| **Total Assets** | $320.0M | $426.3M | $279.3M |
| Accounts Payable | $1.45M | $3.23M | $4.33M |
| Other Current Liabilities | $485K | $760K | $360K |
| **Total Current Liabilities** | $23.61M | $15.09M | $6.23M |
| Other Non-Current Liabilities | $210K | $206K | $0 |
| **Total Non-Current Liabilities** | $2.70M | $23.91M | $21.34M |
| **Total Liabilities** | $26.31M | $39.01M | $27.57M |
| **Total Debt (incl. Leases)** | $4.34M | $4.83M | $1.88M |
| Common Stock | $2.0K | $2.0K | $0 |
| Retained Earnings | -$470.5M | -$360.2M | -$163.9M |
| Accumulated Other Comp. Income | -$2.08M | $526K | -$40K |
| **Total Stockholders' Equity** | $259.9M | $353.6M | -$132.8M |
| Total Equity | $293.6M | $387.3M | -$98.07M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $103.5M | $104.1M | $102.3M | $79.22M | $78.86M | $134.3M | $139.9M | $228.2M |
| Short-Term Investments | $148.8M | $163.2M | $184.2M | $223.1M | $232.9M | $195.0M | $229.3M | $155.1M |
| **Cash & Short-Term Investments** | $252.2M | $267.3M | $286.5M | $302.4M | $311.7M | $329.3M | $369.1M | $383.2M |
| **Total Current Assets** | $257.8M | $273.1M | $296.1M | $312.8M | $324.2M | $343.7M | $386.1M | $399.6M |
| Property, Plant & Equipment, Net | $2.36M | $2.56M | $2.84M | $3.12M | $3.13M | $2.99M | $2.92M | $1.88M |
| Other Non-Current Assets | $20K | $20K | $20K | $20K | $37K | $39K | $50K | $51K |
| **Total Non-Current Assets** | $5.10M | $5.70M | $6.53M | $7.19M | $27.60M | $28.11M | $27.34M | $26.70M |
| **Total Assets** | $262.9M | $278.8M | $302.6M | $320.0M | $351.8M | $371.8M | $413.5M | $426.3M |
| Accounts Payable | $6.23M | $1.91M | $5.43M | $1.45M | $2.02M | $1.23M | $7.93M | $3.23M |
| Other Current Liabilities | $1.62M | $996K | $1.96M | $485K | $387K | $738K | $979K | $760K |
| **Total Current Liabilities** | $25.63M | $21.64M | $25.93M | $23.61M | $22.03M | $21.75M | $25.15M | $15.09M |
| Other Non-Current Liabilities | $213K | $210K | $217K | $210K | $200K | $208K | $207K | $206K |
| **Total Non-Current Liabilities** | $1.16M | $1.65M | $2.23M | $2.70M | $23.22M | $23.87M | $23.55M | $23.91M |
| **Total Liabilities** | $26.79M | $23.29M | $28.16M | $26.31M | $45.24M | $45.62M | $48.71M | $39.01M |
| **Total Debt (incl. Leases)** | $2.84M | $3.30M | $3.92M | $4.34M | $4.77M | $5.46M | $4.72M | $4.83M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$540.2M | -$516.2M | -$494.6M | -$470.5M | -$452.2M | -$430.4M | -$388.0M | -$360.2M |
| Accumulated Other Comp. Income | -$3.22M | -$3.33M | -$1.53M | -$2.08M | -$3.84M | -$1.40M | -$690K | $526K |
| **Total Stockholders' Equity** | $202.3M | $221.7M | $240.7M | $259.9M | $272.8M | $292.4M | $331.0M | $353.6M |
| Total Equity | $236.1M | $255.5M | $274.4M | $293.6M | $306.6M | $326.2M | $364.8M | $387.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- |
| Net Income | -$110.3M | -$196.3M | -$139.6M |
| Depreciation & Amortization | $1.01M | $525K | $76K |
| Stock-Based Compensation | $19.15M | $8.66M | $5.18M |
| Change in Payables | -$1.71M | -$1.71M | $4.16M |
| **Operating Cash Flow** | -$99.19M | -$164.0M | -$98.14M |
| Capital Expenditure | -$1.84M | -$947K | -$886K |
| **Free Cash Flow** | -$101.0M | -$164.9M | -$99.03M |
| Purchases of Investments | -$303.1M | -$155.0M | $0 |
| **Investing Cash Flow** | -$69.20M | -$155.9M | -$886K |
| **Financing Cash Flow** | $1.71M | $313.3M | $309.8M |
| **Net Change in Cash** | -$168.9M | -$6.17M | $211.1M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$24.04M | -$21.62M | -$24.05M | -$18.28M | -$21.90M | -$42.39M | -$27.73M | -$21.20M |
| Depreciation & Amortization | $300K | $300K | $324K | $317K | $200K | $200K | $271K | $247K |
| Stock-Based Compensation | $4.54M | $4.49M | $4.28M | $5.21M | $4.74M | $4.53M | $4.67M | $3.38M |
| Change in Payables | $4.47M | -$3.50M | $3.98M | -$614K | $866K | -$5.74M | $3.78M | $982K |
| **Operating Cash Flow** | -$15.86M | -$19.32M | -$17.63M | -$30.71M | -$15.96M | -$39.41M | -$13.10M | -$30.38M |
| Capital Expenditure | -$160K | -$50K | -$19K | -$235K | -$937K | -$329K | -$344K | -$788K |
| **Free Cash Flow** | -$16.02M | -$19.37M | -$17.65M | -$30.95M | -$16.90M | -$39.74M | -$13.45M | -$31.17M |
| Purchases of Investments | -$40.31M | -$41.98M | -$45.83M | -$42.77M | -$134.2M | -$32.77M | -$93.36M | -$155.0M |
| **Investing Cash Flow** | $15.53M | $21.97M | $40.54M | $11.00M | -$38.51M | $33.65M | -$75.33M | -$155.8M |
| **Financing Cash Flow** | -- | -- | -- | $0 | $0 | $1.71M | $0 | $305.0M |
| **Net Change in Cash** | -$602K | $1.72M | $23.11M | -$19.64M | -$55.48M | -$5.45M | -$88.33M | $119.2M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- |
| Return on Equity (ROE) | -42.4% | -55.5% | -- |
| Return on Assets (ROA) | -34.5% | -46.0% | -50.0% |
| Current Ratio | 13.24x | 26.48x | 44.45x |
| Quick Ratio | 12.81x | 25.39x | 40.86x |
| Debt to Equity | 0.02x | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -43.5% | -38.7% | -44.3% | -42.4% | -41.5% | -35.7% | -49.1% | -55.5% |
| Return on Assets (ROA) | -33.5% | -30.8% | -35.2% | -34.5% | -32.2% | -28.1% | -39.3% | -46.0% |
| Current Ratio | 10.06x | 12.62x | 11.42x | 13.24x | 14.72x | 15.80x | 15.35x | 26.48x |
| Quick Ratio | 9.84x | 12.35x | 11.05x | 12.81x | 14.15x | 15.14x | 14.67x | 25.39x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
